MTEMQ (Molecular Templates) Other Current Assets: $1.56 Mil (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MTEMQ Molecular Templates Inc MTEMQ
12 GF Score
Price $0.00
View Full Analysis

What is Molecular Templates Other Current Assets?

Molecular Templates MTEMQ 12 Other Current Assets is $1.56 Mil as of Jun. 2024. GuruFocus rates MTEMQ with a GF Score™ of 12/100.

Molecular Templates's other current assets for the quarter that ended in Jun. 2024 was $1.56 Mil.

Molecular Templates's quarterly other current assets declined from Dec. 2023 ($5.00 Mil) to Mar. 2024 ($3.50 Mil) and declined from Mar. 2024 ($3.50 Mil) to Jun. 2024 ($1.56Mil).

Molecular Templates's annual other current assets increased from Dec. 2021 ($5.17 Mil) to Dec. 2022 ($7.25 Mil) declined from Dec. 2022 ($7.25 Mil) to Dec. 2023 ($5.00 Mil).


Molecular Templates Other Current Assets Related Terms


Molecular Templates Other Current Assets Historical Data

* Premium members only.

The historical data trend for Molecular Templates's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecular Templates Other Current Assets Chart

Molecular Templates Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.31 5.27 5.17 7.25 5.00

Molecular Templates Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.60 6.89 5.00 3.50 1.56
MTEMQ
12GF Score
Molecular Templates Inc MTEMQ
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Molecular Templates Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of $1.56 Mil mean?
Molecular Templates (MTEMQ) has a Other Current Assets of $1.56 Mil as of Jun. 2024. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Molecular Templates.
Is Molecular Templates' Other Current Assets too high?
Molecular Templates' current Other Current Assets is $1.56 Mil. Overall, Molecular Templates has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Molecular Templates' Other Current Assets compare to GRTSQ and ARTHQ?
Molecular Templates' Other Current Assets of $1.56 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Biotechnology company?
A good Other Current Assets depends on the Biotechnology industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Molecular Templates. Molecular Templates's current Other Current Assets is $1.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molecular Templates stock overvalued right now?
Molecular Templates (MTEMQ) has a current Other Current Assets of $1.56 Mil. The current Other Current Assets is $1.56 Mil. Molecular Templates' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For Molecular Templates (MTEMQ), the current Other Current Assets is $1.56 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Molecular Templates Business Description

Address 9301 Amberglen Boulevard, Suite 100, Austin, TX, USA, 78729
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
12GF Score

Get the complete analysis for MTEMQ

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price